Recall Record

El Paso, TX, United States

CareFusion 213, LLC recalls

12 recalls recorded since 2018, most recently on 9 July 2026. 7 are listed as ongoing. Status and classification are as published by the FDA.

Recalls12
Ongoing (FDA)7
Terminated or completed5
Class I (FDA)6

Ongoing Class II Drugs

Recall started
9 July 2026
Reason
Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0690-2026

Ongoing Class II Drugs

Recall started
11 June 2026
Reason
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
Distribution
Distributed Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0643-2026, D-0646-2026, D-0652-2026, D-0651-2026, D-0650-2026, D-0644-2026, D-0647-2026, D-0649-2026, D-0648-2026, D-0645-2026

Ongoing Class I, Class II Drugs

Recall started
28 May 2026
Reason
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
Distribution
Nationwide inthe USA, as well as other foreign distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0622-2026, D-0623-2026, D-0624-2026, D-0625-2026

Ongoing Class II Drugs

Recall started
22 April 2026
Reason
Lack of assurance of Sterility: potential product contamination
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0518-2026, D-0517-2026

Ongoing Class II Drugs

Recall started
17 December 2025
Reason
Lack of Assurance of Sterlity
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0243-2026

Ongoing Class II Drugs

Recall started
15 May 2025
Reason
Lack of Assurance of Sterility: The affected product may exhibit an open seal on the packaging of the applicator.
Distribution
Nationwide in the U.S.
Initiated
Voluntary: Firm initiated
Recall number
D-0441-2025

Ongoing Class I Drugs

Recall started
14 February 2025
Reason
Non-Sterility: contamination of Aspergillus penicillioides, due to breach in package lidding.
Distribution
Nationwide and Canada
Initiated
Voluntary: Firm initiated
Recall number
D-0259-2025

Completed Class II Drugs

Recall started
25 August 2023
Reason
Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month expiry. Stability studies indicate that the impacted lots, if stored at 30¿C/75% relative humidity continuously beyond 12 months, may exhibit growth of Aspergillus penicillioides.
Distribution
Distributed nationwide to 100 consignees. Please refer to consignee list.
Initiated
Voluntary: Firm initiated
Recall number
D-1168-2023

Terminated Class I Drugs

Recall started
20 April 2021
Terminated
21 June 2023
Reason
Defective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0373-2021

Terminated Class I, Class II Drugs

Recall started
19 March 2021
Terminated
29 September 2022
Reason
Microbial Contamination of Non-Sterile Product.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.
Distribution
Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0345-2021, D-0343-2021, D-0350-2021, D-0344-2021, D-0348-2021, D-0347-2021, D-0346-2021, D-0349-2021

Terminated Class I Drugs

Recall started
7 July 2020
Terminated
29 September 2022
Reason
Microbial Contamination of Non-Sterile Products:Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.
Distribution
Distributed in Puerto Rico and Oman
Initiated
Voluntary: Firm initiated
Recall numbers
D-0266-2021, D-0265-2021, D-0268-2021, D-0267-2021

Terminated Class I Drugs

Recall started
23 June 2020
Terminated
28 September 2022
Reason
Non-Sterility: Product is being recalled due to presence of Aspergillus Penicilloides
Distribution
Puerto Rico, Guam, United Arab Emirates, Bahrain, Brazil, Democratic Republic of the Congo, Chile, Colombia, United Kingdom of Great Britain and Northern Ireland, Hong Kong, Israel, Kuwait, Oman, Qatar, Saudi Arabia, Singapore,
Initiated
Voluntary: Firm initiated
Recall numbers
D-1510-2020, D-1509-2020, D-1511-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.